Fingerprint
Dive into the research topics of 'Two-year follow-up of a randomized phase III clinical trial of nivolumab vs. the investigator's choice of therapy in the Asian population for recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically